Trending Topic: Taxus news and headlines
MediaFetcher Taxus News
Boston Scientific's CEO Discusses Q4 2011 Results - Earnings Call Transcript - Seeking Alpha
Boston Scientific's CEO Discusses Q4 2011 Results - Earnings Call Transcript - Seeking Alpha
Boston Scientific's CEO Discusses Q4 2011 Results - Earnings Call Transcript Seeking Alpha We also continued patient enrollment in the TUXEDO trial to assess the TAXUS Element or ION Stent in diabetic patients. We now have a total approaching 500 patients at almost 40 sites initiated. Earlier this week, we announced the creation of an ... |
Boston Scientific's CEO Discusses Q4 2011 Results - Earnings Call Transcript - Seeking Alpha
Late Lumen Loss Less With Polymer-Free Stent - MedPage Today
Late Lumen Loss Less With Polymer-Free Stent - MedPage Today
 TCTMD | Late Lumen Loss Less With Polymer-Free Stent MedPage Today A polymer-free drug-eluting stent appeared better at preventing late lumen loss than a paclitaxel-eluting stent (Taxus), researchers found. In a noninferiority trial among patients having percutaneous coronary intervention (PCI) for de novo lesions, ... NEXT Up: Polymer-Free SES Angiographically Superior to Taxus |
Late Lumen Loss Less With Polymer-Free Stent - MedPage Today
InspireMD Appoints Dr. James Barry to Its Board of Directors - MarketWatch (press release)
InspireMD Appoints Dr. James Barry to Its Board of Directors - MarketWatch (press release)
InspireMD Appoints Dr. James Barry to Its Board of Directors MarketWatch (press release) Dr. Barry is an experienced medical technology executive and former senior executive at Boston Scientific with a proven track record of bringing products to market, including the TAXUS® paclitaxel-eluting coronary stent. Ofir Paz, InspireMD's Chief ... |
InspireMD Appoints Dr. James Barry to Its Board of Directors - MarketWatch (press release)
Forget the winter blues, it's time to make yours a garden for all seasons - This is Cornwall
Forget the winter blues, it's time to make yours a garden for all seasons - This is Cornwall
Forget the winter blues, it's time to make yours a garden for all seasons This is Cornwall Using a mix of plants helps to create contrast, especially during the winter months, evergreen Taxus baccata AGM, 'English Yew', has for centuries been used as a manicured finely clipped hedge within the English landscape; its rich dark green foliage ... |
Forget the winter blues, it's time to make yours a garden for all seasons - This is Cornwall
SCAAR: New-generation DES safer than older DES, BMS - Cardiology Today
SCAAR: New-generation DES safer than older DES, BMS - Cardiology Today
SCAAR: New-generation DES safer than older DES, BMS Cardiology Today Data were compiled on implantations using bare metal stents (BMS); older-generation drug-eluting stents (DES), including Cypher and Cypher Select (Cordis), Taxus Express and Taxus Liberté (Boston Scientific) and Endeavor (Medtronic); and new-generation ... |
SCAAR: New-generation DES safer than older DES, BMS - Cardiology Today
Boston Scientific Announces First Implant and Market Launch of PROMUS Element ... - MarketWatch (press release)
Boston Scientific Announces First Implant and Market Launch of PROMUS Element ... - MarketWatch (press release)
Boston Scientific Announces First Implant and Market Launch of PROMUS Element ... MarketWatch (press release) The TAXUS® Element Paclitaxel-Eluting Stent System received CE Mark approval in 2010 and is commercialized in the US as the ION(TM) Paclitaxel-Eluting Stent System, where it received FDA approval in 2011. About Boston Scientific Boston Scientific is a ... |
Boston Scientific Announces First Implant and Market Launch of PROMUS Element ... - MarketWatch (press release)
New DES best older stents for deaths, restenosis in latest SCAAR data - TheHeart.Org
New DES best older stents for deaths, restenosis in latest SCAAR data - TheHeart.Org
New DES best older stents for deaths, restenosis in latest SCAAR data TheHeart.Org The older generation DES included Cypher and Cypher Select (Cordis), Taxus Express and Taxus Liberté (Boston Scientific), and Endeavor (Medtronic), and the new DES were Endeavor Resolute (Medtronic), Xience V and Xience Prime (Abbott Laboratories), ... |
New DES best older stents for deaths, restenosis in latest SCAAR data - TheHeart.Org
SYNTAX, FAME trials influence update to PCI/CABG appropriate-use criteria - TheHeart.Org
SYNTAX, FAME trials influence update to PCI/CABG appropriate-use criteria - TheHeart.Org
SYNTAX, FAME trials influence update to PCI/CABG appropriate-use criteria TheHeart.Org It also covers indications for which new clinical trial data have been published since the 2009 statement, especially those in the Synergy Between PCI With TAXUS and Cardiac Surgery (SYNTAX) trial, which compared the two revascularization options in ... |
SYNTAX, FAME trials influence update to PCI/CABG appropriate-use criteria - TheHeart.Org
Gardeners use stilts to cut maze at Longleat House in Wiltshire - Daily Mail
Gardeners use stilts to cut maze at Longleat House in Wiltshire - Daily Mail
 Daily Mail | Gardeners use stilts to cut maze at Longleat House in Wiltshire Daily Mail It is planted entirely of English Yew - Taxus baccata in Latin. For years there has been no easy way out, but recently clever visitors have been using their smart phones to look at the maze from Google Earth. Mr Thompson said: 'We cut the sides twice a ... |
Gardeners use stilts to cut maze at Longleat House in Wiltshire - Daily Mail
SCAAR: Next-gen DES take the lead from BMS for lowest death risk - Mass Device
SCAAR: Next-gen DES take the lead from BMS for lowest death risk - Mass Device
SCAAR: Next-gen DES take the lead from BMS for lowest death risk Mass Device ... which in turn bested bare-metal stents. The study's older-generation DES included Cordis Corp.'s Cypher and Cypher Select; Boston Scientific's Taxus Express and Taxus Liberté; and Medtronic's Endeavor. The BMS were not identified. |
SCAAR: Next-gen DES take the lead from BMS for lowest death risk - Mass Device